Minerva Endocrinologica
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

1.529

-15.9 %

Journal Impact IF Trend

Related Journals

Popular Journals

Minerva Endocrinologica

The 2019-2020 Journal Impact IF of Minerva Endocrinologica is 1.529, which is just updated in 2020.

Minerva Endocrinologica Impact Factor
Highest IF
1.817
Highest Journal Impact IF

The highest Journal Impact IF of Minerva Endocrinologica is 1.817.

Lowest IF
0.981
Lowest Journal Impact IF

The lowest Journal Impact IF of Minerva Endocrinologica is 0.981.

Total Growth Rate
55.9%
IF Total Growth Rate

The total growth rate of Minerva Endocrinologica IF is 55.9%.

Annual Growth Rate
6.2%
IF Annual Growth Rate

The annual growth rate of Minerva Endocrinologica IF is 6.2%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Internal Medicine Q3 76/128

Internal Medicine 41%

Endocrinology Q4 94/118

Endocrinology 20%

Endocrinology, Diabetes and Metabolism Q3 141/217

Endocrinology, Diabetes and Metabolism 35%

Journal Impact IF Ranking

· In the Internal Medicine research field, the Quartile of Minerva Endocrinologica is Q3. Minerva Endocrinologica has been ranked #76 over 128 related journals in the Internal Medicine research category. The ranking percentile of Minerva Endocrinologica is around 41% in the field of Internal Medicine.
· In the Endocrinology research field, the Quartile of Minerva Endocrinologica is Q4. Minerva Endocrinologica has been ranked #94 over 118 related journals in the Endocrinology research category. The ranking percentile of Minerva Endocrinologica is around 20% in the field of Endocrinology.
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Minerva Endocrinologica is Q3. Minerva Endocrinologica has been ranked #141 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Minerva Endocrinologica is around 35% in the field of Endocrinology, Diabetes and Metabolism.

Minerva Endocrinologica Impact Factor 2020-2021 Prediction

Minerva Endocrinologica Impact Factor Predition System

Minerva Endocrinologica Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
1348
Total Citations
8440

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 1.529
2018-2019 1.817
2017-2018 1.26
2016-2017 1.383
2015-2016 1.118
2014-2015 1.464
2013-2014 1.323
2012-2013 1.396
2011-2012 0.981
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Minerva Endocrinologica is 1.529
· The 2018-2019 Journal Impact IF of Minerva Endocrinologica is 1.817
· The 2017-2018 Journal Impact IF of Minerva Endocrinologica is 1.26
· The 2016-2017 Journal Impact IF of Minerva Endocrinologica is 1.383
· The 2015-2016 Journal Impact IF of Minerva Endocrinologica is 1.118
· The 2014-2015 Journal Impact IF of Minerva Endocrinologica is 1.464
· The 2013-2014 Journal Impact IF of Minerva Endocrinologica is 1.323
· The 2012-2013 Journal Impact IF of Minerva Endocrinologica is 1.396
· The 2011-2012 Journal Impact IF of Minerva Endocrinologica is 0.981

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1978 0 1
1982 0 1
1983 0 1
1984 71 1
1985 34 2
1986 40 1
1987 48 2
1988 41 6
1989 41 3
1990 51 3
1991 34 8
1992 28 10
1993 37 12
1994 31 6
1995 28 26
1996 20 26
1997 19 19
1998 17 25
1999 22 36
2000 13 45
2001 40 34
2002 28 59
2003 27 118
2004 23 168
2005 18 198
2006 22 306
2007 26 308
2008 32 376
2009 28 429
2010 24 445
2011 30 435
2012 34 534
2013 40 527
2014 34 594
2015 32 552
2016 64 550
2017 38 495
2018 74 555
2019 28 616
2020 120 853
2021 10 54
Publications Cites Dataset

· The Minerva Endocrinologica has published 0 reports and received 1 citations in 1978.
· The Minerva Endocrinologica has published 0 reports and received 1 citations in 1982.
· The Minerva Endocrinologica has published 0 reports and received 1 citations in 1983.
· The Minerva Endocrinologica has published 71 reports and received 1 citations in 1984.
· The Minerva Endocrinologica has published 34 reports and received 2 citations in 1985.
· The Minerva Endocrinologica has published 40 reports and received 1 citations in 1986.
· The Minerva Endocrinologica has published 48 reports and received 2 citations in 1987.
· The Minerva Endocrinologica has published 41 reports and received 6 citations in 1988.
· The Minerva Endocrinologica has published 41 reports and received 3 citations in 1989.
· The Minerva Endocrinologica has published 51 reports and received 3 citations in 1990.
· The Minerva Endocrinologica has published 34 reports and received 8 citations in 1991.
· The Minerva Endocrinologica has published 28 reports and received 10 citations in 1992.
· The Minerva Endocrinologica has published 37 reports and received 12 citations in 1993.
· The Minerva Endocrinologica has published 31 reports and received 6 citations in 1994.
· The Minerva Endocrinologica has published 28 reports and received 26 citations in 1995.
· The Minerva Endocrinologica has published 20 reports and received 26 citations in 1996.
· The Minerva Endocrinologica has published 19 reports and received 19 citations in 1997.
· The Minerva Endocrinologica has published 17 reports and received 25 citations in 1998.
· The Minerva Endocrinologica has published 22 reports and received 36 citations in 1999.
· The Minerva Endocrinologica has published 13 reports and received 45 citations in 2000.
· The Minerva Endocrinologica has published 40 reports and received 34 citations in 2001.
· The Minerva Endocrinologica has published 28 reports and received 59 citations in 2002.
· The Minerva Endocrinologica has published 27 reports and received 118 citations in 2003.
· The Minerva Endocrinologica has published 23 reports and received 168 citations in 2004.
· The Minerva Endocrinologica has published 18 reports and received 198 citations in 2005.
· The Minerva Endocrinologica has published 22 reports and received 306 citations in 2006.
· The Minerva Endocrinologica has published 26 reports and received 308 citations in 2007.
· The Minerva Endocrinologica has published 32 reports and received 376 citations in 2008.
· The Minerva Endocrinologica has published 28 reports and received 429 citations in 2009.
· The Minerva Endocrinologica has published 24 reports and received 445 citations in 2010.
· The Minerva Endocrinologica has published 30 reports and received 435 citations in 2011.
· The Minerva Endocrinologica has published 34 reports and received 534 citations in 2012.
· The Minerva Endocrinologica has published 40 reports and received 527 citations in 2013.
· The Minerva Endocrinologica has published 34 reports and received 594 citations in 2014.
· The Minerva Endocrinologica has published 32 reports and received 552 citations in 2015.
· The Minerva Endocrinologica has published 64 reports and received 550 citations in 2016.
· The Minerva Endocrinologica has published 38 reports and received 495 citations in 2017.
· The Minerva Endocrinologica has published 74 reports and received 555 citations in 2018.
· The Minerva Endocrinologica has published 28 reports and received 616 citations in 2019.
· The Minerva Endocrinologica has published 120 reports and received 853 citations in 2020.
· The Minerva Endocrinologica has published 10 reports and received 54 citations in 2021.
· The total publications of Minerva Endocrinologica is 1348.
· The total citations of Minerva Endocrinologica is 8440.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Minerva Endocrinologica | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Minerva Endocrinologica Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Minerva Endocrinologica during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Minerva Endocrinologica.

History

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Use

The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor

Pros:

  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
Cons:
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.

Criticism

Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Minerva Endocrinologica
Journal Profile

About

Minerva Endocrinologica publishes scientific papers on endocrine system diseases. Manuscripts may be submitted in the form of editorials, original articles, review articles, special articles, letters to the Editor and guidelines. The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work. None

Highly Cited Keywords

ISSN
0391-1977
ISSN

The ISSN of Minerva Endocrinologica is 0391-1977 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
1827-1634
ISSN (Online)

The ISSN (Online) of Minerva Endocrinologica is 1827-1634 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
Edizioni Minerva Medica S.p.A.
Publisher

Minerva Endocrinologica is published by Edizioni Minerva Medica S.p.A. .

Publication Frequency
Quarterly
Publication Frequency

Minerva Endocrinologica publishes reports Quarterly .

Coverage
1984 - Present
Coverage

The Publication History of Minerva Endocrinologica covers 1984 - Present .

Open Access
NO
Open Access

Minerva Endocrinologica is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Minerva Endocrinologica. Minerva Endocrinologica is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
Multiple languages
Language

The language of Minerva Endocrinologica is Multiple languages .

Country/Region
Italy
Country/Region

The publisher of Minerva Endocrinologica is Edizioni Minerva Medica S.p.A. , which locates in Italy .

Selected Articles

Full Title Authors
Full Title Authors
Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy Han Y · Wang M · Shen J · Zhang Z · Zhao M · Huang J · Chen Y · Chen Z · Hu Y · Wang Y · Wang Y
The one-hundred most-cited articles focused on thyroid research: a bibliometric analysis Kim Es · Yoon Dy · Oh Kw · Lee Wy · Yun Ej · Seo Yl · Rho Ys · Rho Ys
Post-transplant diabetes: Diagnosis and management Brian P. Boerner · Vijay Shiva Swamy · Eric Wolatz · Jennifer L. Larsen · Jennifer L. Larsen
Adverse effects of doping with anabolic androgenic steroids (AAS) in competitive athletics, recreational sports and bodybuilding Vorona E · Nieschlag E · Nieschlag E
Role of adipokines and inflammatory markers in postmenopausal hypertension Mose July · Saba Faiz · Abid Yaqub · Abid Yaqub · Prasanna Santhanam · Jillian Douglas · Ronald J. Stanek · Todd Gress · Omolola Olajide · Henry K. Driscoll · Nalini Santanam · Nalini Santanam
Tumor and normal thyroid spheroids: From tissues to Zebrafish Valentina Cirello · Germano Gaudenzi · Elisa Grassi · Carla Colombo · Carla Colombo · Leonardo Vicentini · Stefano Ferrero · Luca Persani · Giovanni Vitale · Laura Fugazzola · Laura Fugazzola · Laura Fugazzola
Endocrine and neuroendocrine cytopathology Massimo Bongiovanni · S. La Rosa · Gerasimos P. Sykiotis · Gerasimos P. Sykiotis
Comparative study of thyroid hormone and antithyroid antibody levels in patients with gestational diabetes mellitus and pregnant patients with diabetes Xu C · Zhang Z · Zhang Z
Correlation between changes in inflammatory cytokines and the combination with hypertension in patients with type 2 diabetes mellitus Qinghua He · Min Dong · Qi Pan · Xiaoxia Wang · Lixin Guo · Lixin Guo
Improvement of bone turnover markers and bone mineral density following treatment of primary aldosteronism Huai H. Loh · Nor Azmi Kamaruddin · Rozman Zakaria · Norlela Sukor · Norlela Sukor
Controlled ovarian stimulation and triggers in in vitro fertilization: protocol personalization key to optimize outcomes Jacqueline Y. Maher · Mindy S. Christianson · Mindy S. Christianson
The relationship between phthalates and obesity: serum and urine concentrations of phthalates Oktar S · Sungur S · Okur R · Yilmaz N · Ustun I · Gokce C · Gokce C
Comparison the relationship between the levels of insulin resistance, hs-CRP, percentage of body fat and serum osteoprotegerin/receptor activator of nuclear factor κβ ligand in prediabetic patients Bilgir O · Yavuz M · Bilgir F · Akan Oy · Bayindir Ag · Mehmet Calan · Bozkaya G · Yuksel A · Yuksel A
Type 1 diabetes from adolescence to adulthood: is there a permanent need for nutrition education and reeducation? Maja Baretić · Martina Matovinovic Osvatic · Eva Pavić · Nada Rabadija · Valentina Uroić · Carolina Koletic · Nataša Rojnić Putarek · Ivana Pavlić Renar · Ivana Pavlić Renar
Hypertriglyceridemic waist in type 1 diabetes patients: prevalence and related factors Fernández-Miró M · Chillarón Jj · Albareda M · Fontserè S · Colom C · Vila L · Pedro-Botet J · Flores Le-Roux Ja · Flores Le-Roux Ja
Fibroblast growth factors: new insights, new targets in the management of diabetes Ioannis Kyrou · Martin O. Weickert · Seley Gharanei · Harpal S. Randeva · Bee K. Tan · Bee K. Tan
Should serum calcitonin be routinely measured in patients presenting with thyroid nodule Tormey Wp · Byrne B · Hill Ad · Sherlock M · Thompson Cj · Thompson Cj
Antidiabetic medications in patients with heart failure Samia El Hayek Mm · Beydoun Mf · Azar St · Azar St
Laparoscopic roux-en-y gastric bypass vs. laparoscopic sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of lipid effects at one year post-surgery Climent E · Benaiges D · Pedro-Botet J · Goday A · Solà I · Ramón Jm · Flores-Le Roux Ja · Checa Má · Checa Má
Iron overload and non-alcoholic fatty liver disease Datz C · Müller E · Aigner E · Aigner E
Pharmacological management of obesity Velazquez A · Apovian Cm · Apovian Cm
Is cardiovascular risk in women with PCOS a real risk? Current insights Papadakis G · Kandaraki E · Papalou O · Vryonidou A · Diamanti-Kandarakis E · Diamanti-Kandarakis E
Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients Müller Hl · Müller Hl
How many patients with TIR3 FNA really have a thyroid neoplasm Angela Pezzolla · Serafina Lattarulo · Andrea Madaro · Giovanni Docimo · Emanuela Lacalendola · Francesco Paolo Prete · Rinaldo Marzaioli · Rinaldo Marzaioli
Lithogenic factors in postmenopausal women with osteoporotic fracture Ochoa-Hortal Rull Ma · Cano-García Mc · Arrabal-Martín M · Arrabal-Polo Ma · Arrabal-Polo Ma
Isolation and expansion of cytokeratin positive progenitor cells from adult murine pancreatic ducts expressing Pdx-1, Nestin, Sox9, MafA and hepatic nuclear factors Ulrich Grabmaier · Isabelle Rottstegge · Monika Offers · Tilmann Ziegler · Christoph Brenner · Bruno Huber · Jochen Seissler · Jochen Seissler
A review on ovarian hyperstimulation syndrome (OHSS) management strategies Eskew Am · Omurtag Kr · Omurtag Kr
The natural progression and outcomes of adrenal incidentaloma: a systematic review and meta-analysis Huai H. Loh · Anne Yee · Huai S. Loh · Norlela Sukor · Nor Azmi Kamaruddin · Nor Azmi Kamaruddin
Parathyroid carcinoma: a clinical and genetic perspective Filomena Cetani · Elena Pardi · Claudio Marcocci · Claudio Marcocci
Imaging in primary hyperparathyroidism: focus on the evidence-based diagnostic performance of different methods Giorgio Treglia · Trimboli P · Huellner M · Giovanella L · Giovanella L
What is new in 2017? Update on fertility preservation in cancer patients K. Winkler-Crepaz · B. Böttcher · B. Toth · L. Wildt · S. Hofer-Tollinger · S. Hofer-Tollinger
The anti-inflammatory protein kallistatin is associated with carotid intima media thickness in women with polycystic ovary syndrome Mehmet Calan · Guler A · Unal Kocabas G · Alarslan P · Bicer M · Imamoglu C · Yuksel A · Bozkaya G · Bilgir O · Bilgir O
Role of positron emission tomography in thyroid and neuroendocrine tumours Giorgio Treglia · Alexander Kroiss · Arnoldo Piccardo · Filippo Lococo · Prasanna Santhanam · Alessio Imperiale · Alessio Imperiale
Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes A. Mandurino-Mirizzi · Sergio Leonardi · Chiara Melloni · Chiara Melloni
Difficult management in parathyroid carcinoma with synchronous parathyroid hyperplasia Pagni F · Casella G · Bosisio Fm · Costantini M · Fioretta G · Nicoletti G · Baldini · Di Bella C · Di Bella C
Bone metabolism in non alcoholic fatty liver disease: vitamin D status and bone mineral density Eshraghian A · Eshraghian A
Endocrine and metabolic disorders interplaying with nonalcoholic fatty liver disease Polyzos Sa · Polyzos Sa
Insulin treatment may not be associated with worse prognosis in acute heart failure diabetic patients Filipe M. Cunha · Pedro Marques · Joana B. Pereira · Maria João Pinto · Patrícia Rodrigues · Helena Moreira · Patrícia Lourenço · Paulo Bettencourt · Paulo Bettencourt
Prevalence, etiology and management of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome Makri E · Tziomalos K · Tziomalos K
Antenatal oral glucose tolerance test in women with gestational diabetes mellitus: fasting plasma glucose is the best predictor of both large for-gestational-age newborns and postpartum glucose tolerance Monroy G · Tundidor D · Orellana I · García-Patterson A · Adelantado Jm · Corcoy R · Corcoy R
Diabetes mellitus and non-alcoholic fatty liver disease: the thread of Ariadne Kosmidou M · Milionis H · Milionis H
Intestinal hormones, gut microbiota and nonalcoholic fatty liver disease (NAFLD) Koukias N · Buzzetti E · Tsochatzis Ea · Tsochatzis Ea
Hypogonadism and non-alcoholic fatty liver disease Mintziori G · Poulakos P · Tsametis C · Goulis Dg · Goulis Dg
Adipose tissue, obesity and nonalcoholic fatty liver disease Polyzos Sa · Kountouras J · Mantzoros Cs · Mantzoros Cs
Adrenal disorders and nonalcoholic fatty liver disease Papanastasiou L · Fountoulakis S · Vatalas Ia · Vatalas Ia
Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion González-Ortiz M · Méndez-Del Villar M · Martínez-Abundis E · Ramírez-Rodríguez Am · Ramírez-Rodríguez Am
Elastosonography scoring and strain index of thyroid nodules with Hurthle cells Tuzun D · Ersoy R · Kilicyazgan A · Kiyak G · Yalcin S · Cakir B · Cakir B
Novel acquisitions in the diagnosis of medullary thyroid carcinoma Trimboli P · Crescenzi A · Saggiorato E · Giorgio Treglia · Giovanella L · Giovanella L
Ruminant trans-fatty acids and risk of breast cancer: a systematic review and meta-analysis of observational studies Kolahdouz Mohammadi R · Bagheri M · Kolahdouz Mohammadi M · Shidfar F · Shidfar F
Pressure pain threshold and Beta-endorphins plasma level are higher in lean polycystic ovary syndrome women Kiałka M · Milewicz T · Mrozińska S · Rogatko I · Sztefko K · Majewska R · Majewska R
Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on negative and positive symptoms of (type 2) diabetic peripheral neuropathy Han Y · Wang M · Shen J · Zhang Z · Zhao M · Huang J · Chen Y · Chen Z · Hu Y · Wang Y · Wang Y
Role of 99mTc-HYNIC-Tyr3-octreotide scintigraphy in neuroendocrine tumors based on localization of the primary tumor Jiménez Londoño Ga · García Vicente Am · Soriano Castrejón Am · Gómez López Ov · Palomar Muñoz A · Vega Caicedo Ch · Cordero García Jm · Cordero García Jm
Iron overload and nonalcoholic fatty liver disease Datz C · Müller E · Aigner E · Aigner E
Clinicopathological prognostic and theranostic markers in pituitary tumors Vasiljevic A · Jouanneau E · Trouillas J · Raverot G · Raverot G
Insulin resistance and androgen levels in eugonadic and hypogonadic women with prolactinoma Dogan Ba · Berker D · Arduc A · Tuna Mm · Nasiroglu Ni · Karakiliç E · Basaran Mn · Isik S · Tutuncu Y · Unal M · Guler S · Guler S
The complex genetic basis of congenital hypogonadotropic hypogonadism Valeria Vezzoli · Paolo Duminuco · Ivan Bassi · Fabiana Guizzardi · Luca Persani · Marco Bonomi · Marco Bonomi
Fibrocalculous pancreatic diabetes Goundan P · Junqueira A · Kelleher-Yassen D · Steenkamp D · Steenkamp D
The impact of combined interpretation of localization studies on image-guided surgical approaches for primary hyperparathyroidism Tunca F · Akici M · Iscan Y · Sormaz Ic · Giles Senyurek Y · Terzioglu T · Terzioglu T
Is retesting in growth hormone deficient children really useful Cristina Meazza · Chiara Gertosio · Sara Pagani · Alba Pilotta · Carmine Tinelli · Fabio Buzi · Giovanni Farello · Giulia Genoni · Gianni Bona · Mauro Bozzola · Mauro Bozzola
The zebrafish: an emerging animal model for investigating the hypothalamic regulation of reproduction Ivan Bassi · Valentina Andre · Federica Marelli · Valeria Vezzoli · Giorgio R. Merlo · Anna Cariboni · Luca Persani · Yoav Gothilf · Marco Bonomi · Marco Bonomi
A review of prevention strategies for gestational diabetes: is there a missing X-factor? Castorino K · Bradley Pk · Truong L · Martinez J · Martinez J
The effect of chronic estrogen application on bile and gallstone composition in women with cholelithiasis Sieron D · Czerny B · Sieron-Stoltny K · Karasiewicz M · Bogacz A · Seremak-Mrozikiewicz A · Kotrych D · Boron D · Mrozikiewicz Pm · Mrozikiewicz Pm
Expression patterns of cytokeratin 5/6 and p63 in thyroid sporadic nodular goiter Handra-Luca A · Handra-Luca A
Medication adherence and the use of new pharmaceutical formulations: the case of levothyroxine Cristina Scavone · Liberata Sportiello · Daniela Cimmaruta · Maria Giuseppa Sullo · Bonaventura Vitelli · Concetta Rafaniello · Tiziano Fossati · Francesco Rossi · Francesco Rossi
Role of myokines in the maintenance of whole-body metabolic homeostasis Tatiana Y. Kostrominova · Tatiana Y. Kostrominova
Vitamin D status, body composition and glycemic control in Polish adolescents with type 1 diabetes Wierzbicka E · Szalecki M · Pludowski P · Jaworski M · Brzozowska A · Brzozowska A
Is late-onset hypogonadotropic hypogonadism a specific age-dependent disease, or merely an epiphenomenon caused by accumulating disease-burden? Giovanni Corona · Elisa Maseroli · Giulia Rastrelli · Davide Francomano · Antonio Aversa · Geoffrey Hackett · Simona Ferri · Alessandra Sforza · Mario Maggi · Mario Maggi
Pre-existing diabetes in pregnancy Padmanabhan S · Zen M · Lee · Cheung Nw · Cheung Nw
Management of lymphocytic hypophysitis Karaca Z · Kelestimur F · Kelestimur F
Effectiveness and safety of liraglutide after three years of treatment Ponzani P · Scardapane M · Nicolucci A · Rossi Mc · Rossi Mc
Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity Sulemon Chaudhry · Marilia Bernardes · Paul E. Harris · Antonella Maffei · Antonella Maffei
Current approach to treatments for prolactinomas Tirosh A · Shimon I · Shimon I
Association between retinol binding protein 4 with atherosclerotic markers in obese children Nalini Santanam · Elitsur Y · Ronald J. Stanek · Hotiana M · Wheaton J · Kheetan R · Aljayoussi R · Todd Gress · Abid Yaqub · Abid Yaqub
Fasting glycemia at the first prenatal visit and pregnancy outcomes in russian women Popova P · Tkachuk A · Dronova A · Gerasimov A · Kravchuk E · Bolshakova M · Rozdestvenskaya O · Demidova K · Grineva En · Grineva En
Modulation of circulating vasoactive peptides and extracellular matrix proteins are two novel mechanisms in the cardioprotective action of acarbose Natalia Rudovich · O Pivovarova · Wolfgang Bernigau · Andrea Sparwasser · Tacke C · Murahovshi · Mertes G · Andreas L. Birkenfeld · Andreas Bergmann · Martin O. Weickert · Andreas F.H. Pfeiffer · Andreas F.H. Pfeiffer
Effects of short term mild L-Thyroxine suppression therapy on myocardial functions, and its assessment with tissue Doppler imaging Bozkus Y · Sunger A · Yildirir A · Bascil Tutuncu N · Bascil Tutuncu N
The effect of dietary carbohydrates in women with polycystic ovary syndrome: a systematic review Johanna M Frary · Kamilla P. Bjerre · Dorte Glintborg · Pernille Ravn · Pernille Ravn
Leucine and lysine intakes are highly associated with serum adiponectin levels in asymptomatic adults Mohorko N · Jenko-Pražnika Z · Petelin A · Petelin A
Current status and future directions of pharmacological therapy for acromegaly Mercado M · Espinosa E · Ramírez C · Ramírez C
Management of Pituitary Disease Shimon I · Shimon I
Lifestyle changes in the management of adulthood and childhood obesity Francesco Orio · Domenico Tafuri · Antonio Ascione · Francesca Marciano · Silvia Savastano · Giorgio Colarieti · Marcello Orio · Annamaria Colao · Stefano Palomba · Giovanna Muscogiuri · Giovanna Muscogiuri
The possible impact of Advanced Glycation End products on pregnancy outcome in women with Diabetes Mellitus type 1 Magdalena Pertyńska-Marczewska · Katarzyna Cypryk · Katarzyna Cypryk
Overexpression of protein tyrosine phosphatase 1B impairs glucose-stimulated insulin secretion in INS-1 cells Lu B · Gu P · Xu Y · Ye X · Yaru Wang · Du H · Shao Jq · Shao Jq
Gestational diabetes mellitus diagnosis and treatment goals: measurement and measures Popova P · Castorino K · Grineva En · Kerr D · Kerr D
Perinephric adipose tissue thickness in relation to blood pressure, plasma apelin and C-reactive protein levels in obese adolescents Cebeci An · Guven A · Kuru Li · Kuru Li
Pregnancy and pituitary adenomas Glezer A · Jallad Rs · Machado Mc · Fragoso Mc · Bronstein · Bronstein
Late endocrine effects of cancer and cancer therapies in survivors of childhood malignancies Marques P · Van Huellen H · Fitzpatrick A · Maralyn Druce · Maralyn Druce
The association of serum parathyriod hormone and calcium levels with primary aldosteronism: a meta-analysis Zhang Y · Feng B · Feng B
Are basal and glucagon-stimulated C-peptide values predictors of response to GLP-1 receptor agonists in type 2 diabetic patients? Maiza Jc · Gérard P · Rollot O · Cogne M · Jarlet E · Schneebeli S · Schneebeli S
Diabetes mellitus and heart failure: a review of the use of antidiabetic medications in patients with heart failure Samia El Hayek Mm · Beydoun Mf · Azar St · Azar St
Serum heart type fatty acid binding protein levels are not changed in hyperthyroidism Ozbek M · Gungunes A · Sahin M · Ginis Z · Ucan B · Sayki M · Tutal E · Cakal E · Kuşkonmaz Sm · Öztürk Ma · Delibasi T · Delibasi T
Congenital GnRH deficiency: a complex and genetically heterogeneous disease affecting human fertility and sexual development Marco Bonomi · Richard Quinton · Richard Quinton · Richard Quinton
Hypogonadotropic hypogonadism and metabolic syndrome: insights from the high-fat diet experimental rabbit animal model Annamaria Morelli · Linda Vignozzi · Mario Maggi · Mario Maggi
Congenital hypogonadotropic hypogonadism: implications of absent mini-puberty Andrew A. Dwyer · Channa N. Jayasena · Richard Quinton · Richard Quinton
Micro-carcinoma: only a diagnostic epidemic? Del Rio P · Montana Montana C · Mingardi G · Piva G · Sianesi M · Corcione L · Corcione L
Endoscopic imaging in the management of gastroenteropancreatic neuroendocrine tumors Rinaldo Pellicano · Sharmila Fagoonee · Fiorella Altruda · M. Bruno · Giorgio Saracco · Claudio De Angelis · Claudio De Angelis
Diabetes mellitus and cardiovascular disease: strategies for prevention Grineva E · Grineva E
Novel perspectives on hypothalamic-pituitary dysfunction as a risk factor for nonalcoholic fatty liver disease Anika H · MüLLER Hl · MüLLER Hl
The role of semaphorin signaling in the etiology of hypogonadotropic hypogonadism Lettieri A · Oleari R · Gimmelli J · ANDRé · Anna Cariboni · Anna Cariboni
The management of hypophysitis Karaca Z · Kelestimur F · Kelestimur F
Neuroradiological findings in hypogonadotropic hypogonadism Salvalaggio A · Elefante A · Manara R · Manara R
Endoscopic imaging in the management of gastroenteropancreatic neuroendocrine tumors: update for endocrinologists Rinaldo Pellicano · Sharmila Fagoonee · Fiorella Altruda · M. Bruno · Giorgio Saracco · Giorgio Saracco
Gamma knife radiosurgery for pituitary adenomas Ježková J · Marek J · Marek J
Bariatric surgery as an option for diabetes mellitus prevention and treatment in obese persons Ugale S · Agarwal D · Satwalekar · Rao N · Ugale A · Ugale A

Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy
Minerva Endocrinologica | 2018
Han Y · Wang M · Shen J · Zhang Z · Zhao M · Huang J · Chen Y · Chen Z · Hu Y · Wang Y · Wang Y
Post-transplant diabetes: Diagnosis and management
Minerva Endocrinologica | 2018
Brian P. Boerner · Vijay Shiva Swamy · Eric Wolatz · Jennifer L. Larsen · Jennifer L. Larsen
Role of adipokines and inflammatory markers in postmenopausal hypertension
Minerva Endocrinologica | 2018
Mose July · Saba Faiz · Abid Yaqub · Abid Yaqub · Prasanna Santhanam · Jillian Douglas · Ronald J. Stanek · Todd Gress · Omolola Olajide · Henry K. Driscoll · Nalini Santanam · Nalini Santanam